Cargando…

Exenatide induces carcinoembryonic antigen‐related cell adhesion molecule 1 expression to prevent hepatic steatosis

Exenatide, a glucagon‐like peptide‐1 receptor agonist, induces insulin secretion. Its role in insulin clearance has not been adequately examined. Carcinoembryonic antigen‐related cell adhesion molecule 1 (CEACAM1) promotes hepatic insulin clearance to maintain insulin sensitivity. Feeding C57BL/6J m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghadieh, Hilda E., Muturi, Harrison T., Russo, Lucia, Marino, Christopher C., Ghanem, Simona S., Khuder, Saja S., Hanna, Julie C., Jash, Sukanta, Puri, Vishwajeet, Heinrich, Garrett, Gatto‐Weis, Cara, Lee, Kevin Y., Najjar, Sonia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776867/ https://www.ncbi.nlm.nih.gov/pubmed/29404511 http://dx.doi.org/10.1002/hep4.1117

Ejemplares similares

Insulin Sensitivity Is Retained in Mice with Endothelial Loss of Carcinoembryonic Antigen Cell Adhesion Molecule 1
por: Muturi, Harrison T., et al.
Publicado: (2021)

SAT-174 Loss of CEACAM1 in Endothelial Cells Causes Hepatic Fibrogenesis
por: Muturi, Harrison, et al.
Publicado: (2019)

Reduced Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Obesity
por: Heinrich, Garrett, et al.
Publicado: (2017)

SAT-151 Hyperinsulinemia-Driven Progressive Metabolic Dysfunction in Male Mice with Liver-Specific CEACAM1 Deletion
por: Ghadieh, Hilda, et al.
Publicado: (2019)

Loss of Hepatic Carcinoembryonic Antigen‐Related Cell Adhesion Molecule 1 Links Nonalcoholic Steatohepatitis to Atherosclerosis
por: Ghadieh, Hilda E., et al.
Publicado: (2020)

SUN-079 Loss of Endothelial CEACAM1 Induces Atherogenic Fibrous Plaque Formation
por: Abu Helal, Raghd, et al.
Publicado: (2019)

Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease
por: Heinrich, Garrett, et al.
Publicado: (2017)

CIDEA Transcriptionally Regulates UCP1 for Britening and Thermogenesis in Human Fat Cells
por: Jash, Sukanta, et al.
Publicado: (2019)

Aortic Fibrosis in Insulin-Sensitive Mice with Endothelial Cell-Specific Deletion of Ceacam1 Gene
por: Abu Helal, Raghd, et al.
Publicado: (2022)

High-calorie diet exacerbates prostate neoplasia in mice with haploinsufficiency of Pten tumor suppressor gene
por: Liu, Jehnan, et al.
Publicado: (2015)

Role of Insulin Clearance in Insulin Action and Metabolic Diseases
por: Ghadieh, Hilda E., et al.
Publicado: (2023)

Regulation of Insulin Clearance by Non-Esterified Fatty Acids
por: Najjar, Sonia M., et al.
Publicado: (2022)

Hepatic CEACAM1 Over-Expression Protects Against Diet-Induced Fibrosis and Inflammation in White Adipose Tissue
por: Lester, Sumona G., et al.
Publicado: (2015)

Reassessment of the Hispanic Disparity: Hepatic Steatosis Is More Prevalent in Mexican Americans Than Other Hispanics
por: Shaheen, Magda, et al.
Publicado: (2021)

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene
por: Russo, Lucia, et al.
Publicado: (2018)

Nicotinamide Mononucleotide Prevents Free Fatty Acid-Induced Reduction in Glucose Tolerance by Decreasing Insulin Clearance
por: Nahle, Ashraf, et al.
Publicado: (2021)

Effects of Transient Hypoxia versus Prolonged Hypoxia on Satellite Cell Proliferation and Differentiation In Vivo
por: Jash, Sukanta, et al.
Publicado: (2015)

Pathogenic Infections during Pregnancy and the Consequences for Fetal Brain Development
por: Jash, Sukanta, et al.
Publicado: (2022)

Chlorogenic acid/chromium supplement rescues diet-induced insulin resistance and obesity in mice
por: Ghadieh, Hilda E, et al.
Publicado: (2015)

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1: A Link Between Insulin and Lipid Metabolism
por: DeAngelis, Anthony M., et al.
Publicado: (2008)

Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
por: Vetter, Marion L., et al.
Publicado: (2019)

Population pharmacokinetics of exenatide
por: Cirincione, Brenda, et al.
Publicado: (2016)

Carcinoembryonic Cell Adhesion-Related Molecule 2 Regulates Insulin Secretion and Energy Balance
por: Salaheldeen, Elsaid, et al.
Publicado: (2019)

Carcinoembryonic Antigen and Smoking
por: Clarke, C. A., et al.
Publicado: (1982)

Cigarette Smoking among Adolescents in Northwest Ohio: Correlates of Prevalence and Age at Onset
por: Khuder, Sadik A., et al.
Publicado: (2008)

Long-acting preparations of exenatide
por: Cai, Yunpeng, et al.
Publicado: (2013)

Exenatide: A New Promising Antidiabetic Agent
por: Chakraborti, C. K.
Publicado: (2010)

Carcinoembryonic antigen (CEA) "fingerprints".
por: Rule, A. H., et al.
Publicado: (1973)

Carcinoembryonic antigen in hepatocellular cancer.
por: Macnab, G. M., et al.
Publicado: (1978)

Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023)

Several Carcinoembryonic Antigens (CD66) Serve as Receptors for Gonococcal Opacity Proteins
por: Chen, Tie, et al.
Publicado: (1997)

Carcinoembryonic Antigen and Smoking
por: Clarke, Cyril, et al.
Publicado: (1980)

The use of exenatide in severely burned pediatric patients
por: Mecott, Gabriel A, et al.
Publicado: (2010)

Effect of renal impairment on the pharmacokinetics of exenatide
por: Linnebjerg, Helle, et al.
Publicado: (2007)

Evolution of Exenatide as a Diabetes Therapeutic
por: Bhavsar, Sunil, et al.
Publicado: (2013)

Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice
por: Tatarkiewicz, K, et al.
Publicado: (2014)

Fat‐Specific Protein 27 Regulation of Vascular Function in Human Obesity
por: Karki, Shakun, et al.
Publicado: (2019)

Variability in and predictors of glycaemic responses after 24 weeks of treatment with exenatide twice daily and exenatide once weekly
por: Shaw, Jonathan E., et al.
Publicado: (2017)

Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease
por: Li, Shan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fjdu537e2482cehpvap7ecneq1